Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 3;13(23):e035080.
doi: 10.1161/JAHA.124.035080. Epub 2024 Nov 29.

Loss of Endothelial APOE4 Dysregulates Neural Function In Vivo

Affiliations

Loss of Endothelial APOE4 Dysregulates Neural Function In Vivo

Felecia M Marottoli et al. J Am Heart Assoc. .

Abstract

Background: We recently found that loss of endothelial cell APOE3 disrupts neurovascular and synaptic function. However, whether endothelial APOE4 is detrimental or protective for neural function under physiological conditions is unknown. Therefore, the goal of this study was to determine the role of endothelial cell APOE4 in regulating brain function in vivo.

Methods and results: We developed APOE4fl/fl/Cdh5(PAC)-CreERT2+/- and APOE4fl/fl/Cdh5(PAC)-CreERT2-/- (control) mice. Knockdown of endothelial cell APOE4 was induced at ≈4 to 5 weeks of age. Experiments were conducted at 9 months of age to evaluate neurovascular and neuronal function via biochemistry, immunohistochemistry, behavior tests, and electrophysiology. Endothelial cell APOE4 knockdown resulted in higher neurovascular permeability, lower claudin-5 vessel coverage, impaired trace fear memory extinction, and disruption of cortical excitatory-inhibitory balance of synaptic activity.

Conclusions: Our data support the novel concept that endothelial cell APOE4 is protective for brain function when other cell types express APOE4.

Keywords: ApoE4; behavior; brain endothelial cells.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1. Endothelial cell APOE4 knockdown results in higher neurovascular permeability.
Neurovascular permeability was measured in APOE4 fl/fl/Cdh5(PAC)‐CreERT2−/− (APOE4 Cre−/−) and APOE4 fl/fl/Cdh5(PAC)‐CreERT2+/− (APOE4 Cre+/−) mice. A, ApoE protein levels in ex vivo‐isolated brain endothelial cells evaluated by western blot. ApoE protein levels are ≈69% lower in APOE4 Cre+/− mice compared with APOE4 Cre−/− mice [F (1, 18)=31.729; P<0.001], n≈5. B and C, Cortical plasma protein levels measured by ELISA. B, There is an effect of both Cre Genotype [F (1, 38)=6.424; P=0.016] and Sex [F (1, 38)=22.573; P<0.001], n≈10, on IgG levels in cortical homogenates. Cortical IgG levels are ≈17% higher in APOE4 Cre+/− compared with APOE4 Cre−/− mice (middle) and ≈34% higher in female mice compared with males (right). Representative images demonstrate higher levels of IgG in APOE4 Cre+/− (middle) and female (right) mice. Scale bar=10 μm. C, Cortical fibrinogen levels trend ≈20% higher in APOE4 Cre+/− mice compared with APOE4 Cre−/− mice [F (1, 41)=3.067; P=0.088], n≈10. Representative images highlight higher levels of fibrinogen in APOE4 Cre+/− mice. Scale bar=10 μm. D, Quantitative immunohistochemistry of claudin‐5 levels in the cortical neurovasculature. Claudin‐5 levels are ≈10% lower with endothelial APOE4 knockdown when normalized to CD31+ vessel area [F (1, 22)=5.264; P=0.033], n≈6. Representative images reveal less claudin‐5 in the cortical vasculature and a greater number of areas lacking claudin‐5 entirely (white arrowheads) in APOE4 Cre+/− mice compared with APOE4 Cre−/− mice. Scale bar=20 μm. All data are expressed as a box plot depicting the minimum score, the lower quartile (25%), the median (50%, horizontal line), the upper quartile (75%), maximum values, and mean (+). Data were analyzed using GLM. *P<0.05 for APOE4 Cre+/− vs APOE4 Cre−/− mice or female vs male mice. ApoE indicates apolipoprotein E (protein); APOE4, apolipoprotein E4 (gene); APOE4 Cre−/− and Cre−, APOE4 fl/fl/Cdh5(PAC)‐CreERT2−/−; APOE4 Cre+/− and Cre+APOE4 fl/fl/Cdh5(PAC)‐CreERT2+/−; F, female; GLM, general linear models; IgG, immunoglobulin G; and M, male.
Figure 2
Figure 2. Loss of endothelial cell APOE4 disrupts fear extinction and neural function.
Fear memory extinction and neural function were measured in APOE4 fl/fl/Cdh5(PAC)‐CreERT2−/− (APOE4 Cre−/−) and APOE4 fl/fl/Cdh5(PAC)‐CreERT2+/− (APOE4 Cre+/−) mice. A through D, Acquisition and extinction of fear conditioned freezing behavior measured in trace fear conditioning. A, There are no differences in the acquisition of fear memory with endothelial APOE4 knockdown; “H” designates the habituation phase. B, During the extinction phase, there is both a Trial×Cre Genotype [F (3.564)=3.723; P=0.009] and a Trial×Sex interaction [F (3.564)=3.016; P=0.025], n≈9. The Trial×Cre Genotype interaction (middle) is driven by the fact that APOE4 Cre−/− mice begin to extinguish fear memory by trials 11–15 whereas APOE4 Cre+/− mice do not begin to extinguish until trials 21 to 25. In addition, freezing responses are higher in APOE4 Cre+/− compared with APOE4 Cre−/− mice in trials 16 to 30. The Trial×Sex interaction (right) is due to female mice freezing to a greater extent than male mice in trials 1 to 20. C, Plots of fear memory extinction separated by Cre Genotype and Sex to visualize differences in freezing behavior between the first and last trials. Qualitatively, the extent of overall extinction appears less in APOE4 Cre+/− mice when comparing the final trials (26, 27, 28, 29, 30) to the first trials (1, 2, 3, 4, 5). D, Overall extinction was quantified by an EI(EI=(1−[% FreezingTrials 26–30/% FreezingTrials 1–5])×100). Extinction of fear memory is lower in APOE4 Cre+/− compared with APOE4 Cre−/− mice [F (1, 33)=17.578; P<0.001], n ≈ 9. E through H, Ex vivo recordings of spontaneous PSC from excitatory (−60 mV) and inhibitory (+15 mV) synapses onto layer V pyramidal neurons from the prefrontal cortex (n=17 neurons per Cre genotype; 5 mice per Cre genotype). E, There is an interaction of Holding Potential×Cre Genotype on the frequency of PSCs driven by both a lower frequency of excitatory synaptic events and a higher frequency of inhibitory synaptic events in APOE4 Cre+/− mice compared with APOE4 Cre−/− mice [F (1,67)=37.358; P<0.001]. F, Thus, the E‐I ratio (PSC‐60mV/PSC+15mV) was imbalanced (< 1) in APOE4 Cre+/− mice [F (1, 33)=276.937; P<0.001]. G, Simple linear regression of inhibitory vs excitatory synaptic events. Visually the slope calculated from APOE4 Cre+/− (slope=1.877) mice is supralinear compared with the curve derived from APOE4 Cre−/− mice (slope=0.9373). H, Representative traces of spontaneous postsynaptic events recorded at both −60 mV and +15 mV holding potentials (scale bar=25pA/1s). A and B, Data expressed as mean±SEM analyzed using GLM with repeated measures. Asterisks indicating statistical significance (*/formula image/formula image P<0.05) from Bonferroni post hoc analysis are color coded: *black for APOE4 Cre+/− vs APOE4 Cre−/− mice or male vs female mice, formula imagedark red for trials 1 to 5 vs other trials within APOE4 Cre−/− or male sex, and formula imagelight red for trials 1–5 vs other trials within APOE4 Cre+/− or female sex. D through G, Data are expressed as a box plot depicting the minimum score, the lower quartile (25%), the median (50%, horizontal line), the upper quartile (75%), maximum values, and mean (+). Data were analyzed using GLM. Asterisks indicating statistical significance (*/formula image/formula image P<0.05) from Bonferroni post hoc analysis are color coded: *black for APOE4 Cre+/− vs APOE4 Cre−/− mice (within a holding potential for D through G), formula imagedark red is within APOE4 Cre−/−, and <formula imagelight red is within APOE4 Cre+/−. ApoE indicates apolipoprotein E (protein); APOE4; apolipoprotein E4 (gene); APOE4 Cre−/− and Cre‐ indicate APOE4fl/fl/Cdh5(PAC)‐CreERT2−/−; APOE4 Cre+/− and Cre+, APOE4 fl/fl/Cdh5(PAC)‐CreERT2+/−; E‐I, excitatory‐inhibitory; EI, extinction index; F, female; GLM, general linear models; H, habituation; M, male; and PSC, postsynaptic current.

References

    1. Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AW, Bu G. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol. 2016;131:709–723. doi: 10.1007/s00401-016-1547-z - DOI - PMC - PubMed
    1. Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, et al. Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25:1020–1033. doi: 10.1038/s41593-022-01127-0 - DOI - PMC - PubMed
    1. Yamazaki Y, Shinohara M, Yamazaki A, Ren Y, Asmann YW, Kanekiyo T, Bu G. ApoE (apolipoprotein E) in brain pericytes regulates endothelial function in an isoform‐dependent manner by modulating basement membrane components. Arterioscler Thromb Vasc Biol. 2020;40:128–144. doi: 10.1161/ATVBAHA.119.313169 - DOI - PMC - PubMed
    1. Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M. Apolipoprotein E regulates the integrity of tight junctions in an isoform‐dependent manner in an in vitro blood‐brain barrier model. J Biol Chem. 2011;286:17536–17542. doi: 10.1074/jbc.M111.225532 - DOI - PMC - PubMed
    1. Cao Y, Zhu J, Jia P, Zhao Z. scRNASeqDB: a database for RNA‐seq based gene expression profiles in human single cells. Genes (Basel). 2017;8:368. doi: 10.3390/genes8120368 - DOI - PMC - PubMed

LinkOut - more resources